Global Plasma and Serum Proteomics Analysis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Plasma and Serum Proteomics Analysis Service market size was valued at US$ 769 million in 2025 and is forecast to a readjusted size of US$ 1651 million by 2032 with a CAGR of 11.8% during review period.
Plasma and Serum Proteomics Analysis Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Plasma and Serum Proteomics Analysis Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Plasma and Serum Proteomics Analysis Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Plasma and Serum Proteomics Analysis Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Plasma and Serum Proteomics Analysis Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
This report is a detailed and comprehensive analysis for global Plasma and Serum Proteomics Analysis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plasma and Serum Proteomics Analysis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Plasma and Serum Proteomics Analysis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Plasma and Serum Proteomics Analysis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Plasma and Serum Proteomics Analysis Service, with revenue, gross margin, and global market share of Plasma and Serum Proteomics Analysis Service from 2021 to 2026.
Chapter 3, the Plasma and Serum Proteomics Analysis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Plasma and Serum Proteomics Analysis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma and Serum Proteomics Analysis Service.
Chapter 13, to describe Plasma and Serum Proteomics Analysis Service research findings and conclusion.
Plasma and Serum Proteomics Analysis Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Plasma and Serum Proteomics Analysis Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Plasma and Serum Proteomics Analysis Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Plasma and Serum Proteomics Analysis Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Plasma and Serum Proteomics Analysis Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
This report is a detailed and comprehensive analysis for global Plasma and Serum Proteomics Analysis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plasma and Serum Proteomics Analysis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Plasma and Serum Proteomics Analysis Service
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Plasma and Serum Proteomics Analysis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Plasma Proteomics Analysis Service
- Serum Proteomics Analysis Service
- Universities and Research Institutes
- Hospitals
- Pharmaceutical Companies
- Others
- Oncology
- Cardiovascular
- Agriculture
- Neuroscience
- Other
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Plasma and Serum Proteomics Analysis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Plasma and Serum Proteomics Analysis Service, with revenue, gross margin, and global market share of Plasma and Serum Proteomics Analysis Service from 2021 to 2026.
Chapter 3, the Plasma and Serum Proteomics Analysis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Plasma and Serum Proteomics Analysis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma and Serum Proteomics Analysis Service.
Chapter 13, to describe Plasma and Serum Proteomics Analysis Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Plasma and Serum Proteomics Analysis Service by Type
1.3.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type in 2025
1.3.3 Plasma Proteomics Analysis Service
1.3.4 Serum Proteomics Analysis Service
1.4 Classification of Plasma and Serum Proteomics Analysis Service by End User
1.4.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by End User in 2025
1.4.3 Universities and Research Institutes
1.4.4 Hospitals
1.4.5 Pharmaceutical Companies
1.4.6 Others
1.5 Classification of Plasma and Serum Proteomics Analysis Service by Research Areas
1.5.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by Research Areas: 2021 Versus 2025 Versus 2032
1.5.2 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Research Areas in 2025
1.5.3 Oncology
1.5.4 Cardiovascular
1.5.5 Agriculture
1.5.6 Neuroscience
1.5.7 Other
1.6 Global Plasma and Serum Proteomics Analysis Service Market by Application
1.6.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Disease Biomarker Research
1.6.3 Drug Development
1.6.4 Clinical Research
1.6.5 Others
1.7 Global Plasma and Serum Proteomics Analysis Service Market Size & Forecast
1.8 Global Plasma and Serum Proteomics Analysis Service Market Size and Forecast by Region
1.8.1 Global Plasma and Serum Proteomics Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Plasma and Serum Proteomics Analysis Service Market Size by Region, (2021-2032)
1.8.3 North America Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.4 Europe Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.6 South America Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Olink (Thermo Fisher Scientific)
2.1.1 Olink (Thermo Fisher Scientific) Details
2.1.2 Olink (Thermo Fisher Scientific) Major Business
2.1.3 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.1.4 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
2.2 SomaLogic (Illumina)
2.2.1 SomaLogic (Illumina) Details
2.2.2 SomaLogic (Illumina) Major Business
2.2.3 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.2.4 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 SomaLogic (Illumina) Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Plasma and Serum Proteomics Analysis Service Product and Solutions
2.3.4 Labcorp Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 BostonGene
2.4.1 BostonGene Details
2.4.2 BostonGene Major Business
2.4.3 BostonGene Plasma and Serum Proteomics Analysis Service Product and Solutions
2.4.4 BostonGene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 BostonGene Recent Developments and Future Plans
2.5 CellCarta
2.5.1 CellCarta Details
2.5.2 CellCarta Major Business
2.5.3 CellCarta Plasma and Serum Proteomics Analysis Service Product and Solutions
2.5.4 CellCarta Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CellCarta Recent Developments and Future Plans
2.6 GENEWIZ (Azenta Life Sciences)
2.6.1 GENEWIZ (Azenta Life Sciences) Details
2.6.2 GENEWIZ (Azenta Life Sciences) Major Business
2.6.3 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.6.4 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
2.7 CDI Labs
2.7.1 CDI Labs Details
2.7.2 CDI Labs Major Business
2.7.3 CDI Labs Plasma and Serum Proteomics Analysis Service Product and Solutions
2.7.4 CDI Labs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 CDI Labs Recent Developments and Future Plans
2.8 Biognosys
2.8.1 Biognosys Details
2.8.2 Biognosys Major Business
2.8.3 Biognosys Plasma and Serum Proteomics Analysis Service Product and Solutions
2.8.4 Biognosys Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Biognosys Recent Developments and Future Plans
2.9 Discovery Life Sciences
2.9.1 Discovery Life Sciences Details
2.9.2 Discovery Life Sciences Major Business
2.9.3 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
2.9.4 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Discovery Life Sciences Recent Developments and Future Plans
2.10 Firalis Molecular Precision
2.10.1 Firalis Molecular Precision Details
2.10.2 Firalis Molecular Precision Major Business
2.10.3 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Solutions
2.10.4 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Firalis Molecular Precision Recent Developments and Future Plans
2.11 Cell Signaling Technology (CST)
2.11.1 Cell Signaling Technology (CST) Details
2.11.2 Cell Signaling Technology (CST) Major Business
2.11.3 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.11.4 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cell Signaling Technology (CST) Recent Developments and Future Plans
2.12 Sampled (Infinity Biologix)
2.12.1 Sampled (Infinity Biologix) Details
2.12.2 Sampled (Infinity Biologix) Major Business
2.12.3 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.12.4 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sampled (Infinity Biologix) Recent Developments and Future Plans
2.13 APTBIO
2.13.1 APTBIO Details
2.13.2 APTBIO Major Business
2.13.3 APTBIO Plasma and Serum Proteomics Analysis Service Product and Solutions
2.13.4 APTBIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 APTBIO Recent Developments and Future Plans
2.14 Sinotech Genomics
2.14.1 Sinotech Genomics Details
2.14.2 Sinotech Genomics Major Business
2.14.3 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.14.4 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sinotech Genomics Recent Developments and Future Plans
2.15 Biodesix
2.15.1 Biodesix Details
2.15.2 Biodesix Major Business
2.15.3 Biodesix Plasma and Serum Proteomics Analysis Service Product and Solutions
2.15.4 Biodesix Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Biodesix Recent Developments and Future Plans
2.16 Panome Bio
2.16.1 Panome Bio Details
2.16.2 Panome Bio Major Business
2.16.3 Panome Bio Plasma and Serum Proteomics Analysis Service Product and Solutions
2.16.4 Panome Bio Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Panome Bio Recent Developments and Future Plans
2.17 Novogene
2.17.1 Novogene Details
2.17.2 Novogene Major Business
2.17.3 Novogene Plasma and Serum Proteomics Analysis Service Product and Solutions
2.17.4 Novogene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Novogene Recent Developments and Future Plans
2.18 PTM BIO
2.18.1 PTM BIO Details
2.18.2 PTM BIO Major Business
2.18.3 PTM BIO Plasma and Serum Proteomics Analysis Service Product and Solutions
2.18.4 PTM BIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 PTM BIO Recent Developments and Future Plans
2.19 BGI Genomics
2.19.1 BGI Genomics Details
2.19.2 BGI Genomics Major Business
2.19.3 BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.19.4 BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 BGI Genomics Recent Developments and Future Plans
2.20 Evotec
2.20.1 Evotec Details
2.20.2 Evotec Major Business
2.20.3 Evotec Plasma and Serum Proteomics Analysis Service Product and Solutions
2.20.4 Evotec Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Evotec Recent Developments and Future Plans
2.21 Metware Biotechnology
2.21.1 Metware Biotechnology Details
2.21.2 Metware Biotechnology Major Business
2.21.3 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Solutions
2.21.4 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Metware Biotechnology Recent Developments and Future Plans
2.22 MRM Proteomics
2.22.1 MRM Proteomics Details
2.22.2 MRM Proteomics Major Business
2.22.3 MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.22.4 MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 MRM Proteomics Recent Developments and Future Plans
2.23 Lc-Bio Technologies
2.23.1 Lc-Bio Technologies Details
2.23.2 Lc-Bio Technologies Major Business
2.23.3 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Solutions
2.23.4 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Lc-Bio Technologies Recent Developments and Future Plans
2.24 Eurofins Scientific
2.24.1 Eurofins Scientific Details
2.24.2 Eurofins Scientific Major Business
2.24.3 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Solutions
2.24.4 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Eurofins Scientific Recent Developments and Future Plans
2.25 MtoZ-Biolabs
2.25.1 MtoZ-Biolabs Details
2.25.2 MtoZ-Biolabs Major Business
2.25.3 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Solutions
2.25.4 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 MtoZ-Biolabs Recent Developments and Future Plans
2.26 Creative Proteomics
2.26.1 Creative Proteomics Details
2.26.2 Creative Proteomics Major Business
2.26.3 Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.26.4 Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Creative Proteomics Recent Developments and Future Plans
2.27 Macrogen
2.27.1 Macrogen Details
2.27.2 Macrogen Major Business
2.27.3 Macrogen Plasma and Serum Proteomics Analysis Service Product and Solutions
2.27.4 Macrogen Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Macrogen Recent Developments and Future Plans
2.28 TATAA Biocenter
2.28.1 TATAA Biocenter Details
2.28.2 TATAA Biocenter Major Business
2.28.3 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Solutions
2.28.4 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 TATAA Biocenter Recent Developments and Future Plans
2.29 OmicScouts (Momentum Biotechnologies)
2.29.1 OmicScouts (Momentum Biotechnologies) Details
2.29.2 OmicScouts (Momentum Biotechnologies) Major Business
2.29.3 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.29.4 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
2.30 Precision Biomarker Laboratories (PBL)
2.30.1 Precision Biomarker Laboratories (PBL) Details
2.30.2 Precision Biomarker Laboratories (PBL) Major Business
2.30.3 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.30.4 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
2.31 Shanghai OE Biotech
2.31.1 Shanghai OE Biotech Details
2.31.2 Shanghai OE Biotech Major Business
2.31.3 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Solutions
2.31.4 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Shanghai OE Biotech Recent Developments and Future Plans
2.32 RxCelerate
2.32.1 RxCelerate Details
2.32.2 RxCelerate Major Business
2.32.3 RxCelerate Plasma and Serum Proteomics Analysis Service Product and Solutions
2.32.4 RxCelerate Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 RxCelerate Recent Developments and Future Plans
2.33 Proteomics International
2.33.1 Proteomics International Details
2.33.2 Proteomics International Major Business
2.33.3 Proteomics International Plasma and Serum Proteomics Analysis Service Product and Solutions
2.33.4 Proteomics International Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 Proteomics International Recent Developments and Future Plans
2.34 Proteome Sciences
2.34.1 Proteome Sciences Details
2.34.2 Proteome Sciences Major Business
2.34.3 Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
2.34.4 Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 Proteome Sciences Recent Developments and Future Plans
2.35 Westlake Omics
2.35.1 Westlake Omics Details
2.35.2 Westlake Omics Major Business
2.35.3 Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.35.4 Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 Westlake Omics Recent Developments and Future Plans
2.36 Crown Bioscience
2.36.1 Crown Bioscience Details
2.36.2 Crown Bioscience Major Business
2.36.3 Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Solutions
2.36.4 Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 Crown Bioscience Recent Developments and Future Plans
2.37 VProteomics
2.37.1 VProteomics Details
2.37.2 VProteomics Major Business
2.37.3 VProteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.37.4 VProteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 VProteomics Recent Developments and Future Plans
2.38 Shanghai Majorbio Bio-Pharm
2.38.1 Shanghai Majorbio Bio-Pharm Details
2.38.2 Shanghai Majorbio Bio-Pharm Major Business
2.38.3 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Solutions
2.38.4 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
2.39 Applied Biomics
2.39.1 Applied Biomics Details
2.39.2 Applied Biomics Major Business
2.39.3 Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.39.4 Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 Applied Biomics Recent Developments and Future Plans
2.40 Sapient Bioanalytics
2.40.1 Sapient Bioanalytics Details
2.40.2 Sapient Bioanalytics Major Business
2.40.3 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.40.4 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.40.5 Sapient Bioanalytics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Plasma and Serum Proteomics Analysis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Plasma and Serum Proteomics Analysis Service by Company Revenue
3.2.2 Top 3 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
3.2.3 Top 6 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
3.3 Plasma and Serum Proteomics Analysis Service Market: Overall Company Footprint Analysis
3.3.1 Plasma and Serum Proteomics Analysis Service Market: Region Footprint
3.3.2 Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
3.3.3 Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Plasma and Serum Proteomics Analysis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Plasma and Serum Proteomics Analysis Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Plasma and Serum Proteomics Analysis Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
6.2 North America Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2032)
6.3 North America Plasma and Serum Proteomics Analysis Service Market Size by Country
6.3.1 North America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
6.3.2 United States Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
6.3.3 Canada Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
6.3.4 Mexico Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
7.2 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
7.3 Europe Plasma and Serum Proteomics Analysis Service Market Size by Country
7.3.1 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
7.3.2 Germany Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.3 France Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.5 Russia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.6 Italy Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region
8.3.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2032)
8.3.2 China Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.3 Japan Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.4 South Korea Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.5 India Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.7 Australia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
9.2 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
9.3 South America Plasma and Serum Proteomics Analysis Service Market Size by Country
9.3.1 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
9.3.2 Brazil Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
9.3.3 Argentina Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country
10.3.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
10.3.2 Turkey Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
10.3.4 UAE Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Plasma and Serum Proteomics Analysis Service Market Drivers
11.2 Plasma and Serum Proteomics Analysis Service Market Restraints
11.3 Plasma and Serum Proteomics Analysis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Plasma and Serum Proteomics Analysis Service Industry Chain
12.2 Plasma and Serum Proteomics Analysis Service Upstream Analysis
12.3 Plasma and Serum Proteomics Analysis Service Midstream Analysis
12.4 Plasma and Serum Proteomics Analysis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Plasma and Serum Proteomics Analysis Service by Type
1.3.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type in 2025
1.3.3 Plasma Proteomics Analysis Service
1.3.4 Serum Proteomics Analysis Service
1.4 Classification of Plasma and Serum Proteomics Analysis Service by End User
1.4.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by End User in 2025
1.4.3 Universities and Research Institutes
1.4.4 Hospitals
1.4.5 Pharmaceutical Companies
1.4.6 Others
1.5 Classification of Plasma and Serum Proteomics Analysis Service by Research Areas
1.5.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by Research Areas: 2021 Versus 2025 Versus 2032
1.5.2 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Research Areas in 2025
1.5.3 Oncology
1.5.4 Cardiovascular
1.5.5 Agriculture
1.5.6 Neuroscience
1.5.7 Other
1.6 Global Plasma and Serum Proteomics Analysis Service Market by Application
1.6.1 Overview: Global Plasma and Serum Proteomics Analysis Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Disease Biomarker Research
1.6.3 Drug Development
1.6.4 Clinical Research
1.6.5 Others
1.7 Global Plasma and Serum Proteomics Analysis Service Market Size & Forecast
1.8 Global Plasma and Serum Proteomics Analysis Service Market Size and Forecast by Region
1.8.1 Global Plasma and Serum Proteomics Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Plasma and Serum Proteomics Analysis Service Market Size by Region, (2021-2032)
1.8.3 North America Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.4 Europe Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.6 South America Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Olink (Thermo Fisher Scientific)
2.1.1 Olink (Thermo Fisher Scientific) Details
2.1.2 Olink (Thermo Fisher Scientific) Major Business
2.1.3 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.1.4 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
2.2 SomaLogic (Illumina)
2.2.1 SomaLogic (Illumina) Details
2.2.2 SomaLogic (Illumina) Major Business
2.2.3 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.2.4 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 SomaLogic (Illumina) Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Plasma and Serum Proteomics Analysis Service Product and Solutions
2.3.4 Labcorp Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 BostonGene
2.4.1 BostonGene Details
2.4.2 BostonGene Major Business
2.4.3 BostonGene Plasma and Serum Proteomics Analysis Service Product and Solutions
2.4.4 BostonGene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 BostonGene Recent Developments and Future Plans
2.5 CellCarta
2.5.1 CellCarta Details
2.5.2 CellCarta Major Business
2.5.3 CellCarta Plasma and Serum Proteomics Analysis Service Product and Solutions
2.5.4 CellCarta Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CellCarta Recent Developments and Future Plans
2.6 GENEWIZ (Azenta Life Sciences)
2.6.1 GENEWIZ (Azenta Life Sciences) Details
2.6.2 GENEWIZ (Azenta Life Sciences) Major Business
2.6.3 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.6.4 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
2.7 CDI Labs
2.7.1 CDI Labs Details
2.7.2 CDI Labs Major Business
2.7.3 CDI Labs Plasma and Serum Proteomics Analysis Service Product and Solutions
2.7.4 CDI Labs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 CDI Labs Recent Developments and Future Plans
2.8 Biognosys
2.8.1 Biognosys Details
2.8.2 Biognosys Major Business
2.8.3 Biognosys Plasma and Serum Proteomics Analysis Service Product and Solutions
2.8.4 Biognosys Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Biognosys Recent Developments and Future Plans
2.9 Discovery Life Sciences
2.9.1 Discovery Life Sciences Details
2.9.2 Discovery Life Sciences Major Business
2.9.3 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
2.9.4 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Discovery Life Sciences Recent Developments and Future Plans
2.10 Firalis Molecular Precision
2.10.1 Firalis Molecular Precision Details
2.10.2 Firalis Molecular Precision Major Business
2.10.3 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Solutions
2.10.4 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Firalis Molecular Precision Recent Developments and Future Plans
2.11 Cell Signaling Technology (CST)
2.11.1 Cell Signaling Technology (CST) Details
2.11.2 Cell Signaling Technology (CST) Major Business
2.11.3 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.11.4 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cell Signaling Technology (CST) Recent Developments and Future Plans
2.12 Sampled (Infinity Biologix)
2.12.1 Sampled (Infinity Biologix) Details
2.12.2 Sampled (Infinity Biologix) Major Business
2.12.3 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.12.4 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sampled (Infinity Biologix) Recent Developments and Future Plans
2.13 APTBIO
2.13.1 APTBIO Details
2.13.2 APTBIO Major Business
2.13.3 APTBIO Plasma and Serum Proteomics Analysis Service Product and Solutions
2.13.4 APTBIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 APTBIO Recent Developments and Future Plans
2.14 Sinotech Genomics
2.14.1 Sinotech Genomics Details
2.14.2 Sinotech Genomics Major Business
2.14.3 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.14.4 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sinotech Genomics Recent Developments and Future Plans
2.15 Biodesix
2.15.1 Biodesix Details
2.15.2 Biodesix Major Business
2.15.3 Biodesix Plasma and Serum Proteomics Analysis Service Product and Solutions
2.15.4 Biodesix Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Biodesix Recent Developments and Future Plans
2.16 Panome Bio
2.16.1 Panome Bio Details
2.16.2 Panome Bio Major Business
2.16.3 Panome Bio Plasma and Serum Proteomics Analysis Service Product and Solutions
2.16.4 Panome Bio Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Panome Bio Recent Developments and Future Plans
2.17 Novogene
2.17.1 Novogene Details
2.17.2 Novogene Major Business
2.17.3 Novogene Plasma and Serum Proteomics Analysis Service Product and Solutions
2.17.4 Novogene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Novogene Recent Developments and Future Plans
2.18 PTM BIO
2.18.1 PTM BIO Details
2.18.2 PTM BIO Major Business
2.18.3 PTM BIO Plasma and Serum Proteomics Analysis Service Product and Solutions
2.18.4 PTM BIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 PTM BIO Recent Developments and Future Plans
2.19 BGI Genomics
2.19.1 BGI Genomics Details
2.19.2 BGI Genomics Major Business
2.19.3 BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.19.4 BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 BGI Genomics Recent Developments and Future Plans
2.20 Evotec
2.20.1 Evotec Details
2.20.2 Evotec Major Business
2.20.3 Evotec Plasma and Serum Proteomics Analysis Service Product and Solutions
2.20.4 Evotec Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Evotec Recent Developments and Future Plans
2.21 Metware Biotechnology
2.21.1 Metware Biotechnology Details
2.21.2 Metware Biotechnology Major Business
2.21.3 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Solutions
2.21.4 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Metware Biotechnology Recent Developments and Future Plans
2.22 MRM Proteomics
2.22.1 MRM Proteomics Details
2.22.2 MRM Proteomics Major Business
2.22.3 MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.22.4 MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 MRM Proteomics Recent Developments and Future Plans
2.23 Lc-Bio Technologies
2.23.1 Lc-Bio Technologies Details
2.23.2 Lc-Bio Technologies Major Business
2.23.3 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Solutions
2.23.4 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Lc-Bio Technologies Recent Developments and Future Plans
2.24 Eurofins Scientific
2.24.1 Eurofins Scientific Details
2.24.2 Eurofins Scientific Major Business
2.24.3 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Solutions
2.24.4 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Eurofins Scientific Recent Developments and Future Plans
2.25 MtoZ-Biolabs
2.25.1 MtoZ-Biolabs Details
2.25.2 MtoZ-Biolabs Major Business
2.25.3 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Solutions
2.25.4 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 MtoZ-Biolabs Recent Developments and Future Plans
2.26 Creative Proteomics
2.26.1 Creative Proteomics Details
2.26.2 Creative Proteomics Major Business
2.26.3 Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.26.4 Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Creative Proteomics Recent Developments and Future Plans
2.27 Macrogen
2.27.1 Macrogen Details
2.27.2 Macrogen Major Business
2.27.3 Macrogen Plasma and Serum Proteomics Analysis Service Product and Solutions
2.27.4 Macrogen Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Macrogen Recent Developments and Future Plans
2.28 TATAA Biocenter
2.28.1 TATAA Biocenter Details
2.28.2 TATAA Biocenter Major Business
2.28.3 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Solutions
2.28.4 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 TATAA Biocenter Recent Developments and Future Plans
2.29 OmicScouts (Momentum Biotechnologies)
2.29.1 OmicScouts (Momentum Biotechnologies) Details
2.29.2 OmicScouts (Momentum Biotechnologies) Major Business
2.29.3 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.29.4 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
2.30 Precision Biomarker Laboratories (PBL)
2.30.1 Precision Biomarker Laboratories (PBL) Details
2.30.2 Precision Biomarker Laboratories (PBL) Major Business
2.30.3 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Solutions
2.30.4 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
2.31 Shanghai OE Biotech
2.31.1 Shanghai OE Biotech Details
2.31.2 Shanghai OE Biotech Major Business
2.31.3 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Solutions
2.31.4 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Shanghai OE Biotech Recent Developments and Future Plans
2.32 RxCelerate
2.32.1 RxCelerate Details
2.32.2 RxCelerate Major Business
2.32.3 RxCelerate Plasma and Serum Proteomics Analysis Service Product and Solutions
2.32.4 RxCelerate Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 RxCelerate Recent Developments and Future Plans
2.33 Proteomics International
2.33.1 Proteomics International Details
2.33.2 Proteomics International Major Business
2.33.3 Proteomics International Plasma and Serum Proteomics Analysis Service Product and Solutions
2.33.4 Proteomics International Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 Proteomics International Recent Developments and Future Plans
2.34 Proteome Sciences
2.34.1 Proteome Sciences Details
2.34.2 Proteome Sciences Major Business
2.34.3 Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
2.34.4 Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 Proteome Sciences Recent Developments and Future Plans
2.35 Westlake Omics
2.35.1 Westlake Omics Details
2.35.2 Westlake Omics Major Business
2.35.3 Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.35.4 Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 Westlake Omics Recent Developments and Future Plans
2.36 Crown Bioscience
2.36.1 Crown Bioscience Details
2.36.2 Crown Bioscience Major Business
2.36.3 Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Solutions
2.36.4 Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 Crown Bioscience Recent Developments and Future Plans
2.37 VProteomics
2.37.1 VProteomics Details
2.37.2 VProteomics Major Business
2.37.3 VProteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.37.4 VProteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 VProteomics Recent Developments and Future Plans
2.38 Shanghai Majorbio Bio-Pharm
2.38.1 Shanghai Majorbio Bio-Pharm Details
2.38.2 Shanghai Majorbio Bio-Pharm Major Business
2.38.3 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Solutions
2.38.4 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
2.39 Applied Biomics
2.39.1 Applied Biomics Details
2.39.2 Applied Biomics Major Business
2.39.3 Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.39.4 Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 Applied Biomics Recent Developments and Future Plans
2.40 Sapient Bioanalytics
2.40.1 Sapient Bioanalytics Details
2.40.2 Sapient Bioanalytics Major Business
2.40.3 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Solutions
2.40.4 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
2.40.5 Sapient Bioanalytics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Plasma and Serum Proteomics Analysis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Plasma and Serum Proteomics Analysis Service by Company Revenue
3.2.2 Top 3 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
3.2.3 Top 6 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
3.3 Plasma and Serum Proteomics Analysis Service Market: Overall Company Footprint Analysis
3.3.1 Plasma and Serum Proteomics Analysis Service Market: Region Footprint
3.3.2 Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
3.3.3 Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Plasma and Serum Proteomics Analysis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Plasma and Serum Proteomics Analysis Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Plasma and Serum Proteomics Analysis Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
6.2 North America Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2032)
6.3 North America Plasma and Serum Proteomics Analysis Service Market Size by Country
6.3.1 North America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
6.3.2 United States Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
6.3.3 Canada Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
6.3.4 Mexico Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
7.2 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
7.3 Europe Plasma and Serum Proteomics Analysis Service Market Size by Country
7.3.1 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
7.3.2 Germany Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.3 France Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.5 Russia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
7.3.6 Italy Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region
8.3.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2032)
8.3.2 China Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.3 Japan Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.4 South Korea Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.5 India Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
8.3.7 Australia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
9.2 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
9.3 South America Plasma and Serum Proteomics Analysis Service Market Size by Country
9.3.1 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
9.3.2 Brazil Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
9.3.3 Argentina Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country
10.3.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
10.3.2 Turkey Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
10.3.4 UAE Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Plasma and Serum Proteomics Analysis Service Market Drivers
11.2 Plasma and Serum Proteomics Analysis Service Market Restraints
11.3 Plasma and Serum Proteomics Analysis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Plasma and Serum Proteomics Analysis Service Industry Chain
12.2 Plasma and Serum Proteomics Analysis Service Upstream Analysis
12.3 Plasma and Serum Proteomics Analysis Service Midstream Analysis
12.4 Plasma and Serum Proteomics Analysis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Plasma and Serum Proteomics Analysis Service Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 4. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Olink (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 8. Olink (Thermo Fisher Scientific) Major Business
Table 9. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 10. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 12. SomaLogic (Illumina) Company Information, Head Office, and Major Competitors
Table 13. SomaLogic (Illumina) Major Business
Table 14. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 15. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. SomaLogic (Illumina) Recent Developments and Future Plans
Table 17. Labcorp Company Information, Head Office, and Major Competitors
Table 18. Labcorp Major Business
Table 19. Labcorp Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 20. Labcorp Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. BostonGene Company Information, Head Office, and Major Competitors
Table 22. BostonGene Major Business
Table 23. BostonGene Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 24. BostonGene Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. BostonGene Recent Developments and Future Plans
Table 26. CellCarta Company Information, Head Office, and Major Competitors
Table 27. CellCarta Major Business
Table 28. CellCarta Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 29. CellCarta Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. CellCarta Recent Developments and Future Plans
Table 31. GENEWIZ (Azenta Life Sciences) Company Information, Head Office, and Major Competitors
Table 32. GENEWIZ (Azenta Life Sciences) Major Business
Table 33. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 34. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
Table 36. CDI Labs Company Information, Head Office, and Major Competitors
Table 37. CDI Labs Major Business
Table 38. CDI Labs Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 39. CDI Labs Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. CDI Labs Recent Developments and Future Plans
Table 41. Biognosys Company Information, Head Office, and Major Competitors
Table 42. Biognosys Major Business
Table 43. Biognosys Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 44. Biognosys Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Biognosys Recent Developments and Future Plans
Table 46. Discovery Life Sciences Company Information, Head Office, and Major Competitors
Table 47. Discovery Life Sciences Major Business
Table 48. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 49. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Discovery Life Sciences Recent Developments and Future Plans
Table 51. Firalis Molecular Precision Company Information, Head Office, and Major Competitors
Table 52. Firalis Molecular Precision Major Business
Table 53. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 54. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Firalis Molecular Precision Recent Developments and Future Plans
Table 56. Cell Signaling Technology (CST) Company Information, Head Office, and Major Competitors
Table 57. Cell Signaling Technology (CST) Major Business
Table 58. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 59. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Cell Signaling Technology (CST) Recent Developments and Future Plans
Table 61. Sampled (Infinity Biologix) Company Information, Head Office, and Major Competitors
Table 62. Sampled (Infinity Biologix) Major Business
Table 63. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 64. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sampled (Infinity Biologix) Recent Developments and Future Plans
Table 66. APTBIO Company Information, Head Office, and Major Competitors
Table 67. APTBIO Major Business
Table 68. APTBIO Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 69. APTBIO Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. APTBIO Recent Developments and Future Plans
Table 71. Sinotech Genomics Company Information, Head Office, and Major Competitors
Table 72. Sinotech Genomics Major Business
Table 73. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 74. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Sinotech Genomics Recent Developments and Future Plans
Table 76. Biodesix Company Information, Head Office, and Major Competitors
Table 77. Biodesix Major Business
Table 78. Biodesix Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 79. Biodesix Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Biodesix Recent Developments and Future Plans
Table 81. Panome Bio Company Information, Head Office, and Major Competitors
Table 82. Panome Bio Major Business
Table 83. Panome Bio Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 84. Panome Bio Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Panome Bio Recent Developments and Future Plans
Table 86. Novogene Company Information, Head Office, and Major Competitors
Table 87. Novogene Major Business
Table 88. Novogene Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 89. Novogene Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Novogene Recent Developments and Future Plans
Table 91. PTM BIO Company Information, Head Office, and Major Competitors
Table 92. PTM BIO Major Business
Table 93. PTM BIO Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 94. PTM BIO Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. PTM BIO Recent Developments and Future Plans
Table 96. BGI Genomics Company Information, Head Office, and Major Competitors
Table 97. BGI Genomics Major Business
Table 98. BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 99. BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. BGI Genomics Recent Developments and Future Plans
Table 101. Evotec Company Information, Head Office, and Major Competitors
Table 102. Evotec Major Business
Table 103. Evotec Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 104. Evotec Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Evotec Recent Developments and Future Plans
Table 106. Metware Biotechnology Company Information, Head Office, and Major Competitors
Table 107. Metware Biotechnology Major Business
Table 108. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 109. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Metware Biotechnology Recent Developments and Future Plans
Table 111. MRM Proteomics Company Information, Head Office, and Major Competitors
Table 112. MRM Proteomics Major Business
Table 113. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 114. MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. MRM Proteomics Recent Developments and Future Plans
Table 116. Lc-Bio Technologies Company Information, Head Office, and Major Competitors
Table 117. Lc-Bio Technologies Major Business
Table 118. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 119. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Lc-Bio Technologies Recent Developments and Future Plans
Table 121. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 122. Eurofins Scientific Major Business
Table 123. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 124. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Eurofins Scientific Recent Developments and Future Plans
Table 126. MtoZ-Biolabs Company Information, Head Office, and Major Competitors
Table 127. MtoZ-Biolabs Major Business
Table 128. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 129. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. MtoZ-Biolabs Recent Developments and Future Plans
Table 131. Creative Proteomics Company Information, Head Office, and Major Competitors
Table 132. Creative Proteomics Major Business
Table 133. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 134. Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Creative Proteomics Recent Developments and Future Plans
Table 136. Macrogen Company Information, Head Office, and Major Competitors
Table 137. Macrogen Major Business
Table 138. Macrogen Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 139. Macrogen Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Macrogen Recent Developments and Future Plans
Table 141. TATAA Biocenter Company Information, Head Office, and Major Competitors
Table 142. TATAA Biocenter Major Business
Table 143. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 144. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. TATAA Biocenter Recent Developments and Future Plans
Table 146. OmicScouts (Momentum Biotechnologies) Company Information, Head Office, and Major Competitors
Table 147. OmicScouts (Momentum Biotechnologies) Major Business
Table 148. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 149. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
Table 151. Precision Biomarker Laboratories (PBL) Company Information, Head Office, and Major Competitors
Table 152. Precision Biomarker Laboratories (PBL) Major Business
Table 153. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 154. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
Table 156. Shanghai OE Biotech Company Information, Head Office, and Major Competitors
Table 157. Shanghai OE Biotech Major Business
Table 158. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 159. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Shanghai OE Biotech Recent Developments and Future Plans
Table 161. RxCelerate Company Information, Head Office, and Major Competitors
Table 162. RxCelerate Major Business
Table 163. RxCelerate Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 164. RxCelerate Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. RxCelerate Recent Developments and Future Plans
Table 166. Proteomics International Company Information, Head Office, and Major Competitors
Table 167. Proteomics International Major Business
Table 168. Proteomics International Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 169. Proteomics International Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Proteomics International Recent Developments and Future Plans
Table 171. Proteome Sciences Company Information, Head Office, and Major Competitors
Table 172. Proteome Sciences Major Business
Table 173. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 174. Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Proteome Sciences Recent Developments and Future Plans
Table 176. Westlake Omics Company Information, Head Office, and Major Competitors
Table 177. Westlake Omics Major Business
Table 178. Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 179. Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Westlake Omics Recent Developments and Future Plans
Table 181. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 182. Crown Bioscience Major Business
Table 183. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 184. Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. Crown Bioscience Recent Developments and Future Plans
Table 186. VProteomics Company Information, Head Office, and Major Competitors
Table 187. VProteomics Major Business
Table 188. VProteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 189. VProteomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. VProteomics Recent Developments and Future Plans
Table 191. Shanghai Majorbio Bio-Pharm Company Information, Head Office, and Major Competitors
Table 192. Shanghai Majorbio Bio-Pharm Major Business
Table 193. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 194. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
Table 196. Applied Biomics Company Information, Head Office, and Major Competitors
Table 197. Applied Biomics Major Business
Table 198. Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 199. Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Applied Biomics Recent Developments and Future Plans
Table 201. Sapient Bioanalytics Company Information, Head Office, and Major Competitors
Table 202. Sapient Bioanalytics Major Business
Table 203. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 204. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Sapient Bioanalytics Recent Developments and Future Plans
Table 206. Global Plasma and Serum Proteomics Analysis Service Revenue (USD Million) by Players (2021-2026)
Table 207. Global Plasma and Serum Proteomics Analysis Service Revenue Share by Players (2021-2026)
Table 208. Breakdown of Plasma and Serum Proteomics Analysis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 209. Market Position of Players in Plasma and Serum Proteomics Analysis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 210. Head Office of Key Plasma and Serum Proteomics Analysis Service Players
Table 211. Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
Table 212. Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
Table 213. Plasma and Serum Proteomics Analysis Service New Market Entrants and Barriers to Market Entry
Table 214. Plasma and Serum Proteomics Analysis Service Mergers, Acquisition, Agreements, and Collaborations
Table 215. Global Plasma and Serum Proteomics Analysis Service Consumption Value (USD Million) by Type (2021-2026)
Table 216. Global Plasma and Serum Proteomics Analysis Service Consumption Value Share by Type (2021-2026)
Table 217. Global Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Type (2027-2032)
Table 218. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026)
Table 219. Global Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Application (2027-2032)
Table 220. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 221. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 222. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 223. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 224. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 225. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 226. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 227. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 228. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 229. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 230. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 231. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 232. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 233. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 234. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 235. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 236. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 237. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 238. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 239. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 240. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 241. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 242. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 243. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 244. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 245. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 246. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 247. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 248. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 249. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 250. Global Key Players of Plasma and Serum Proteomics Analysis Service Upstream (Raw Materials)
Table 251. Global Plasma and Serum Proteomics Analysis Service Typical Customers
Table 1. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Plasma and Serum Proteomics Analysis Service Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 4. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Olink (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 8. Olink (Thermo Fisher Scientific) Major Business
Table 9. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 10. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 12. SomaLogic (Illumina) Company Information, Head Office, and Major Competitors
Table 13. SomaLogic (Illumina) Major Business
Table 14. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 15. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. SomaLogic (Illumina) Recent Developments and Future Plans
Table 17. Labcorp Company Information, Head Office, and Major Competitors
Table 18. Labcorp Major Business
Table 19. Labcorp Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 20. Labcorp Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. BostonGene Company Information, Head Office, and Major Competitors
Table 22. BostonGene Major Business
Table 23. BostonGene Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 24. BostonGene Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. BostonGene Recent Developments and Future Plans
Table 26. CellCarta Company Information, Head Office, and Major Competitors
Table 27. CellCarta Major Business
Table 28. CellCarta Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 29. CellCarta Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. CellCarta Recent Developments and Future Plans
Table 31. GENEWIZ (Azenta Life Sciences) Company Information, Head Office, and Major Competitors
Table 32. GENEWIZ (Azenta Life Sciences) Major Business
Table 33. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 34. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
Table 36. CDI Labs Company Information, Head Office, and Major Competitors
Table 37. CDI Labs Major Business
Table 38. CDI Labs Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 39. CDI Labs Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. CDI Labs Recent Developments and Future Plans
Table 41. Biognosys Company Information, Head Office, and Major Competitors
Table 42. Biognosys Major Business
Table 43. Biognosys Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 44. Biognosys Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Biognosys Recent Developments and Future Plans
Table 46. Discovery Life Sciences Company Information, Head Office, and Major Competitors
Table 47. Discovery Life Sciences Major Business
Table 48. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 49. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Discovery Life Sciences Recent Developments and Future Plans
Table 51. Firalis Molecular Precision Company Information, Head Office, and Major Competitors
Table 52. Firalis Molecular Precision Major Business
Table 53. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 54. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Firalis Molecular Precision Recent Developments and Future Plans
Table 56. Cell Signaling Technology (CST) Company Information, Head Office, and Major Competitors
Table 57. Cell Signaling Technology (CST) Major Business
Table 58. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 59. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Cell Signaling Technology (CST) Recent Developments and Future Plans
Table 61. Sampled (Infinity Biologix) Company Information, Head Office, and Major Competitors
Table 62. Sampled (Infinity Biologix) Major Business
Table 63. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 64. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sampled (Infinity Biologix) Recent Developments and Future Plans
Table 66. APTBIO Company Information, Head Office, and Major Competitors
Table 67. APTBIO Major Business
Table 68. APTBIO Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 69. APTBIO Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. APTBIO Recent Developments and Future Plans
Table 71. Sinotech Genomics Company Information, Head Office, and Major Competitors
Table 72. Sinotech Genomics Major Business
Table 73. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 74. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Sinotech Genomics Recent Developments and Future Plans
Table 76. Biodesix Company Information, Head Office, and Major Competitors
Table 77. Biodesix Major Business
Table 78. Biodesix Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 79. Biodesix Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Biodesix Recent Developments and Future Plans
Table 81. Panome Bio Company Information, Head Office, and Major Competitors
Table 82. Panome Bio Major Business
Table 83. Panome Bio Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 84. Panome Bio Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Panome Bio Recent Developments and Future Plans
Table 86. Novogene Company Information, Head Office, and Major Competitors
Table 87. Novogene Major Business
Table 88. Novogene Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 89. Novogene Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Novogene Recent Developments and Future Plans
Table 91. PTM BIO Company Information, Head Office, and Major Competitors
Table 92. PTM BIO Major Business
Table 93. PTM BIO Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 94. PTM BIO Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. PTM BIO Recent Developments and Future Plans
Table 96. BGI Genomics Company Information, Head Office, and Major Competitors
Table 97. BGI Genomics Major Business
Table 98. BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 99. BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. BGI Genomics Recent Developments and Future Plans
Table 101. Evotec Company Information, Head Office, and Major Competitors
Table 102. Evotec Major Business
Table 103. Evotec Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 104. Evotec Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Evotec Recent Developments and Future Plans
Table 106. Metware Biotechnology Company Information, Head Office, and Major Competitors
Table 107. Metware Biotechnology Major Business
Table 108. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 109. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Metware Biotechnology Recent Developments and Future Plans
Table 111. MRM Proteomics Company Information, Head Office, and Major Competitors
Table 112. MRM Proteomics Major Business
Table 113. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 114. MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. MRM Proteomics Recent Developments and Future Plans
Table 116. Lc-Bio Technologies Company Information, Head Office, and Major Competitors
Table 117. Lc-Bio Technologies Major Business
Table 118. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 119. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Lc-Bio Technologies Recent Developments and Future Plans
Table 121. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 122. Eurofins Scientific Major Business
Table 123. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 124. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Eurofins Scientific Recent Developments and Future Plans
Table 126. MtoZ-Biolabs Company Information, Head Office, and Major Competitors
Table 127. MtoZ-Biolabs Major Business
Table 128. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 129. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. MtoZ-Biolabs Recent Developments and Future Plans
Table 131. Creative Proteomics Company Information, Head Office, and Major Competitors
Table 132. Creative Proteomics Major Business
Table 133. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 134. Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Creative Proteomics Recent Developments and Future Plans
Table 136. Macrogen Company Information, Head Office, and Major Competitors
Table 137. Macrogen Major Business
Table 138. Macrogen Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 139. Macrogen Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Macrogen Recent Developments and Future Plans
Table 141. TATAA Biocenter Company Information, Head Office, and Major Competitors
Table 142. TATAA Biocenter Major Business
Table 143. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 144. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. TATAA Biocenter Recent Developments and Future Plans
Table 146. OmicScouts (Momentum Biotechnologies) Company Information, Head Office, and Major Competitors
Table 147. OmicScouts (Momentum Biotechnologies) Major Business
Table 148. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 149. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
Table 151. Precision Biomarker Laboratories (PBL) Company Information, Head Office, and Major Competitors
Table 152. Precision Biomarker Laboratories (PBL) Major Business
Table 153. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 154. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
Table 156. Shanghai OE Biotech Company Information, Head Office, and Major Competitors
Table 157. Shanghai OE Biotech Major Business
Table 158. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 159. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Shanghai OE Biotech Recent Developments and Future Plans
Table 161. RxCelerate Company Information, Head Office, and Major Competitors
Table 162. RxCelerate Major Business
Table 163. RxCelerate Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 164. RxCelerate Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. RxCelerate Recent Developments and Future Plans
Table 166. Proteomics International Company Information, Head Office, and Major Competitors
Table 167. Proteomics International Major Business
Table 168. Proteomics International Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 169. Proteomics International Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Proteomics International Recent Developments and Future Plans
Table 171. Proteome Sciences Company Information, Head Office, and Major Competitors
Table 172. Proteome Sciences Major Business
Table 173. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 174. Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Proteome Sciences Recent Developments and Future Plans
Table 176. Westlake Omics Company Information, Head Office, and Major Competitors
Table 177. Westlake Omics Major Business
Table 178. Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 179. Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Westlake Omics Recent Developments and Future Plans
Table 181. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 182. Crown Bioscience Major Business
Table 183. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 184. Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. Crown Bioscience Recent Developments and Future Plans
Table 186. VProteomics Company Information, Head Office, and Major Competitors
Table 187. VProteomics Major Business
Table 188. VProteomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 189. VProteomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. VProteomics Recent Developments and Future Plans
Table 191. Shanghai Majorbio Bio-Pharm Company Information, Head Office, and Major Competitors
Table 192. Shanghai Majorbio Bio-Pharm Major Business
Table 193. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 194. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
Table 196. Applied Biomics Company Information, Head Office, and Major Competitors
Table 197. Applied Biomics Major Business
Table 198. Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 199. Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Applied Biomics Recent Developments and Future Plans
Table 201. Sapient Bioanalytics Company Information, Head Office, and Major Competitors
Table 202. Sapient Bioanalytics Major Business
Table 203. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Solutions
Table 204. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Sapient Bioanalytics Recent Developments and Future Plans
Table 206. Global Plasma and Serum Proteomics Analysis Service Revenue (USD Million) by Players (2021-2026)
Table 207. Global Plasma and Serum Proteomics Analysis Service Revenue Share by Players (2021-2026)
Table 208. Breakdown of Plasma and Serum Proteomics Analysis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 209. Market Position of Players in Plasma and Serum Proteomics Analysis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 210. Head Office of Key Plasma and Serum Proteomics Analysis Service Players
Table 211. Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
Table 212. Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
Table 213. Plasma and Serum Proteomics Analysis Service New Market Entrants and Barriers to Market Entry
Table 214. Plasma and Serum Proteomics Analysis Service Mergers, Acquisition, Agreements, and Collaborations
Table 215. Global Plasma and Serum Proteomics Analysis Service Consumption Value (USD Million) by Type (2021-2026)
Table 216. Global Plasma and Serum Proteomics Analysis Service Consumption Value Share by Type (2021-2026)
Table 217. Global Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Type (2027-2032)
Table 218. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026)
Table 219. Global Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Application (2027-2032)
Table 220. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 221. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 222. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 223. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 224. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 225. North America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 226. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 227. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 228. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 229. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 230. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 231. Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 232. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 233. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 234. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 235. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 236. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 237. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 238. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 239. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 240. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 241. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 242. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 243. South America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 244. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 245. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 246. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 247. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 248. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 249. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 250. Global Key Players of Plasma and Serum Proteomics Analysis Service Upstream (Raw Materials)
Table 251. Global Plasma and Serum Proteomics Analysis Service Typical Customers
LIST OF FIGURES
Figure 1. Plasma and Serum Proteomics Analysis Service Picture
Figure 2. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type in 2025
Figure 4. Plasma Proteomics Analysis Service
Figure 5. Serum Proteomics Analysis Service
Figure 6. Global Plasma and Serum Proteomics Analysis Service Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by End User in 2025
Figure 8. Universities and Research Institutes
Figure 9. Hospitals
Figure 10. Pharmaceutical Companies
Figure 11. Others
Figure 12. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Research Areas in 2025
Figure 14. Oncology
Figure 15. Cardiovascular
Figure 16. Agriculture
Figure 17. Neuroscience
Figure 18. Other
Figure 19. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application in 2025
Figure 21. Disease Biomarker Research Picture
Figure 22. Drug Development Picture
Figure 23. Clinical Research Picture
Figure 24. Others Picture
Figure 25. Global Plasma and Serum Proteomics Analysis Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Plasma and Serum Proteomics Analysis Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Plasma and Serum Proteomics Analysis Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region in 2025
Figure 30. North America Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Plasma and Serum Proteomics Analysis Service Revenue Share by Players in 2025
Figure 37. Plasma and Serum Proteomics Analysis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Plasma and Serum Proteomics Analysis Service by Player Revenue in 2025
Figure 39. Top 3 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
Figure 40. Top 6 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
Figure 41. Global Plasma and Serum Proteomics Analysis Service Consumption Value Share by Type (2021-2026)
Figure 42. Global Plasma and Serum Proteomics Analysis Service Market Share Forecast by Type (2027-2032)
Figure 43. Global Plasma and Serum Proteomics Analysis Service Consumption Value Share by Application (2021-2026)
Figure 44. Global Plasma and Serum Proteomics Analysis Service Market Share Forecast by Application (2027-2032)
Figure 45. North America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 55. France Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 62. China Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 65. India Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 79. Plasma and Serum Proteomics Analysis Service Market Drivers
Figure 80. Plasma and Serum Proteomics Analysis Service Market Restraints
Figure 81. Plasma and Serum Proteomics Analysis Service Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Plasma and Serum Proteomics Analysis Service Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Plasma and Serum Proteomics Analysis Service Picture
Figure 2. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type in 2025
Figure 4. Plasma Proteomics Analysis Service
Figure 5. Serum Proteomics Analysis Service
Figure 6. Global Plasma and Serum Proteomics Analysis Service Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by End User in 2025
Figure 8. Universities and Research Institutes
Figure 9. Hospitals
Figure 10. Pharmaceutical Companies
Figure 11. Others
Figure 12. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Research Areas in 2025
Figure 14. Oncology
Figure 15. Cardiovascular
Figure 16. Agriculture
Figure 17. Neuroscience
Figure 18. Other
Figure 19. Global Plasma and Serum Proteomics Analysis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application in 2025
Figure 21. Disease Biomarker Research Picture
Figure 22. Drug Development Picture
Figure 23. Clinical Research Picture
Figure 24. Others Picture
Figure 25. Global Plasma and Serum Proteomics Analysis Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Plasma and Serum Proteomics Analysis Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Plasma and Serum Proteomics Analysis Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region in 2025
Figure 30. North America Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Plasma and Serum Proteomics Analysis Service Revenue Share by Players in 2025
Figure 37. Plasma and Serum Proteomics Analysis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Plasma and Serum Proteomics Analysis Service by Player Revenue in 2025
Figure 39. Top 3 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
Figure 40. Top 6 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
Figure 41. Global Plasma and Serum Proteomics Analysis Service Consumption Value Share by Type (2021-2026)
Figure 42. Global Plasma and Serum Proteomics Analysis Service Market Share Forecast by Type (2027-2032)
Figure 43. Global Plasma and Serum Proteomics Analysis Service Consumption Value Share by Application (2021-2026)
Figure 44. Global Plasma and Serum Proteomics Analysis Service Market Share Forecast by Application (2027-2032)
Figure 45. North America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 55. France Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 62. China Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 65. India Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 79. Plasma and Serum Proteomics Analysis Service Market Drivers
Figure 80. Plasma and Serum Proteomics Analysis Service Market Restraints
Figure 81. Plasma and Serum Proteomics Analysis Service Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Plasma and Serum Proteomics Analysis Service Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
